Journal article

The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

Matthew A Roberts, Helen L Pilmore, Francesco L Ierino, Sunil V Badve, Alan Cass, Amit X Garg, Carmel M Hawley, Nicole M Isbel, Henry Krum, Elaine M Pascoe, Andrew M Tonkin, Liza A Vergara, Vlado Perkovic

Nephrology | WILEY | Published : 2015

Grants

Awarded by New Zealand Health Research Council Feasibility Study Grant


Awarded by National Health and Medical Research Council (NHMRC) Project Grant


Awarded by NHMRC Training Fellowship


Funding Acknowledgements

The BLOCADE Feasibility Study acknowledges the following funding sources: Don & Lorraine Jacquot Collaborative Research Initiative Grant (2008), the New Zealand Health Research Council Feasibility Study Grant (10-163), the National Health and Medical Research Council (NHMRC) Project Grant (1006171) and Pfizer CVL (2008). Roche Products, Pty Limited provided Dilatrend(R) at a discounted price. In addition, MAR was supported by an NHMRC Training Fellowship (628902).